Epidemiology
Late menopause: benefits and risks
Longer estrogen exposure is protective for heart and brain but adds cancer surveillance.
Key points
- Longevity favored
- Cancer surveillance
- Individualize screening
Frequently asked questions
Is late menopause good?
Net-favorable for longevity in most cohorts.
Extra screening?
Yes — more endometrial and breast surveillance.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.